Gyre Therapeutics, Inc. (GYRE)
NASDAQ·Healthcare·Biotechnology
$6.76
+0.30%
Mkt Cap $751.43M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$17.00
Range $16.00 – $18.00
Implied Upside
+151.5%
Consensus $17.00 vs current $6.76
NASDAQ·Healthcare·Biotechnology
$6.76
+0.30%
Mkt Cap $751.43M
No recent rating data.
Price Target (2 analysts)
$17.00
Range $16.00 – $18.00
+151.5%
Consensus $17.00 vs current $6.76